One Visit, Multiple Protections: Navigating RSV Vaccine Coadministration

In this episode, “One Visit, Multiple Protections: Navigating RSV Vaccine Coadministration,” the expert pharmacists explore the following questions:

1. What are your operational and communication best practices for the coadministration of the respiratory syncytial virus (RSV) vaccine with those for other illnesses, such as COVID-19 and flu?
2. How are you addressing coadministration for pregnant people who need both Tdap and RSV vaccines?

The panel examined practical strategies for coadministering RSV vaccines alongside those for other respiratory illnesses such as flu and COVID-19. They emphasized the importance of assessing a patient's past vaccine reactions, noting that those who tolerate vaccines well typically have no issue with multiple shots, whereas those prone to systemic reactions may benefit from spacing. The experts also highlighted the operational advantage of initiating coadministration conversations early to create efficiency and improve uptake. For pregnant patients, they noted the delicate timing between Tdap and RSV vaccination, advising that RSV should be prioritized within its narrow 32-to-36-week window to ensure passive immunity transfer to the newborn.

Throughout the conversation, the experts provide a comprehensive reflection on the field and the factors that may shape how clinicians approach care moving forward.